I am an assistant attending and an assistant clinical member in the Department of Medical Physics and Chief of Biomedical Physics and Engineering. I am responsible for maintaining our medical devices and ensuring that they are safe and compliant with regulatory standards. I also investigate new and emerging technologies that have the potential to enhance clinical applications and operational work flow.
Previously, I was engaged in research on human biodynamics and robotic applications in drug development, and in the design and development of radar and electronic warfare systems.
I received a doctorate degree in biomedical engineering from the State University of New York (SUNY) at Binghamton and bachelor’s and master’s degrees in electrical engineering from SUNY Stony Brook. In addition, I am a visiting assistant professor in the Department of Bioengineering at SUNY Binghamton and serve on the technical advisory boards of the Cardiopulmonary Corporation, Emergency Care Research Institute, Radiofrequency Identification (RFID) in Healthcare Consortium, and Institute of Electrical and Electronics Engineers Committee on RFID.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Paul Frisch discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures